BIOMARKERS

CO-CHAIR
Mark Frye, MD | Mayo Clinic
WHY A TASK GROUP?

Formed in November 2012, the Biomarkers task group members are engaged in identifying biological indicators, along with developing and promoting diagnostic tools. The task group uses the results of current investigations to future directions of research.

ABOUT THE BIOMARKER DISCOVERY PROJECT

Visit the ClinicalTrials.gov page: “The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression”. This program has been generously funded by a gift from a University of Michigan Eisenberg Family Depression Center donor.

INTERESTED IN JOINING?

Researchers from our current member institutions should contact Diana Burnett, Program Manager ([email protected]), for more information about being added to the task group.

We are not accepting non-affiliated researchers at this time to our Task Groups. We do, however, encourage researchers who are not from our member institutions to talk to their current institutional leadership about becoming a member of our Network. More information about joining the NNDC can be found on our membership opportunities page: https://nndc.org/membership/